On the other hand, breast cancers that expressed COX2 were infrequently associated with first distant metastases in the skeleton (47 (43.5%) of the 108 COX2-positive cancers vs. 79 (63.7%) of the 124 COX2-negative cancers, P = 0.002). Here, PTGS2 is linked to breast carcinoma.